Filing Details
- Accession Number:
- 0001127602-18-009477
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-02 07:34:48
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-02 07:34:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-28 | 60 | $108.34 | 305,982 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 500 | $108.34 | 305,482 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 100 | $108.35 | 305,382 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 40 | $108.37 | 305,342 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 400 | $108.37 | 304,942 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 200 | $108.44 | 304,742 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 100 | $108.53 | 304,642 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 202 | $108.54 | 304,440 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 100 | $108.64 | 304,340 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 200 | $108.64 | 304,140 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 200 | $108.75 | 303,940 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-28 | 2,264 | $107.82 | 301,676 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,208 | Indirect | 2016 GRAT |
| Common Stock | 29,954 | Indirect | 2017 GRAT |
| Common Stock | 340 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
